Cynata Therapeutics Limited
CYYNF
$0.118
$0.01615.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.50M | 7.29M | 4.14M | 4.05M | 7.61M |
| Total Receivables | 109.10K | 122.30K | 73.10K | 71.50K | 49.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 109.30K | 122.50K | 145.30K | 142.00K | 147.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.20K | 2.50K | 2.40K | 2.30K | 2.40K |
| Total Current Assets | 6.72M | 7.53M | 4.36M | 4.26M | 7.81M |
|
|
|||||
| Total Current Assets | 6.72M | 7.53M | 4.36M | 4.26M | 7.81M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.23M | 1.38M | 1.24M | 1.21M | 1.36M |
| Total Assets | 7.96M | 8.92M | 5.60M | 5.47M | 9.17M |
|
|
|||||
| Total Accounts Payable | 705.10K | 790.00K | 288.20K | 281.60K | 683.10K |
| Total Accrued Expenses | 144.40K | 161.80K | 493.20K | 482.00K | 122.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 849.50K | 951.80K | 781.30K | 763.60K | 805.70K |
|
|
|||||
| Total Current Liabilities | 849.50K | 951.80K | 781.30K | 763.60K | 805.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 849.50K | 951.80K | 781.30K | 763.60K | 805.70K |
|
|
|||||
| Common Stock & APIC | 55.32M | 61.98M | 54.46M | 53.23M | 55.64M |
| Retained Earnings | -53.20M | -59.61M | -54.92M | -53.68M | -52.57M |
| Treasury Stock & Other | 4.99M | 5.59M | 5.28M | 5.16M | 5.29M |
| Total Common Equity | 7.11M | 7.96M | 4.82M | 4.71M | 8.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.11M | 7.96M | 4.82M | 4.71M | 8.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.11M | 7.96M | 4.82M | 4.71M | 8.36M |
|
|
|||||